Exenatide: AC 2993, AC002993, AC2993A, Exendin 4, LY2148568

ISSN： 1174-5886

Source： Drugs in R&D, Vol.5, Iss.1, 2004-01, pp. : 35-40

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Production of Ac-225

Current Radiopharmaceuticals, Vol. 11, Iss. 3, 2018-12 ,pp. : 173-179

Bentham Science Publishers

Access to resources Recommend Favorite

In vivo Evaluation of [²²⁵Ac]Ac-DOTA^ZOL for α-Therapy of Bone Metastases

Current Radiopharmaceuticals, Vol. 11, Iss. 3, 2018-12 ,pp. : 223-230

Bentham Science Publishers

Access to resources Recommend Favorite

Vinorelbine/epirubicin vs AC in operable breast cancer

Inpharma, Vol. 1, Iss. 1515, 2005-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Development of ²²⁵Ac Radiopharmaceuticals: TRIUMF Perspectives and Experiences

Current Radiopharmaceuticals, Vol. 11, Iss. 3, 2018-12 ,pp. : 156-172

Bentham Science Publishers

Access to resources Recommend Favorite

Synthesis and influenza virus sialidase inhibitory activity of analogues of 4-guanidino-Neu5Ac2en (GG167) with modified 5-substituents

By Smith P. Starkey I. Howes P. Sollis S. Keeling S. Cherry P. von Itzstein M. W Y.W. B J.

European Journal of Medicinal Chemistry, Vol. 31, Iss. 2, 1996-01 ,pp. : 143-150

Elsevier

Access to resources Recommend Favorite